Tagged with OP

Opinion Martin Dewhurst, co-leader for McKinsey’s global Pharmaceuticals and Medical Products Practice, discusses the enormous potential value of digital and analytical advancements for R&D.     One of the areas with the most transformational impact is the potential to double R&D productivity over the next five to ten years.   After years of…

France Christophe Cizeron, president of Lyonbiopole, discusses the important economic and industrial position of the research cluster in the Rhone-Alps Region as well as the challenges posed by domestic and international competition.   Between 2007-2016, the number of biotech companies doubled in the Lyon region and there was a sharp increase…

USA Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) discusses the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES) and how it will improve access to medicines and restore healthy competition to the market.    American taxpayers, along with millions of patients, will benefit…

Opinion Mohamed is a passionate Blockchain enthusiast who is committed to helping grow the Blockchain ecosystem around the world. Here he talks about healthcare’s slow adoption of technology and the challenges that come with hefty privacy regulation of patient data.  The life-and-death nature of the industry might be a factor of…

Opinion Richard Saynor, Senior Vice President, Classic and Established Products at GSK urges big pharma to weigh in on improving global health and well-being to achieve the United Nations Sustainable Development Goals.  On the part of pharmaceutical companies, we have a responsibility to help people gain access to high-quality healthcare and…

Innovation Joonho J. Lee is a CEO and CoFounder of Cognita Lab INC developing risk management framework around Artificial Intelligence (AI) in healthcare and financial services industries. Here he discusses the use of blockchain in the healthcare industry and the need to remain “cautiously optimistic.”   Many people asked whether I…

EUROPE The latest EFPIA data on the VAT rates applied to medicines in European countries in 2018.

Spain The global rich list is splattered with household names who have built their reputation not only through business acumen but through eye-catching purchases such as Steve Balmer’s record buyout of the LA Clippers basketball team for a whopping USD two billion in 2016 or Roman Abramovich´s spectacular 162.5 metres yacht…

Digital Health Rhenu Bhuller, a founding member of Frost & Sullivan’s Asia Pacific operations and expert in analysing the impact of cutting-edge tech, looks at pharma’s evolution and adoption of digital health.   The evolution of disease management and the convergence of drugs, devices and digital health in the management of various…

Innovation Carla Smith, Executive Vice President of The Healthcare Information and Management Systems Society (HIMSS) discusses the need to adopt innovation and retrain the workforce to provide healthcare without walls. If we are short-sighted and base our future workforce projections upon outdated models, we will experience a significant shortage in the…

Canada Brian Hilberdink, President of Novo Nordisk Canada, calls for collaboration between government and industry to ensure that Canadian patients get swift access to the best treatments.    As a Canadian who spent several years working globally for a biopharmaceutical company, I saw firsthand how pricing and investment decisions can be made…

France David Kimelfeld, president of Lyon Métropole, speaks out about his plans for the region in terms of industrial innovation and sustainability, describing how Lyon’s historical roots would represent and enhance its future development.   Lyon has become recognized nationally and internationally as possessing all the requisite qualities to host high…